American International Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-40,588
| Closed | -$970 | – | 3402 |
|
|
2021
Q1 | $970 | Buy |
40,588
+107
| +0.3% | +$1.99K | ﹤0.01% | 1469 |
|
|
2020
Q4 | $591 | Sell |
40,481
-1,161
| -3% | -$15.4K | ﹤0.01% | 1661 |
|
|
2020
Q3 | $591K | Buy |
41,642
+209
| +0.5% | +$3.19K | ﹤0.01% | 1516 |
|
|
2020
Q2 | $609K | Buy |
41,433
+8,606
| +26% | +$87.4K | ﹤0.01% | 1498 |
|
|
2020
Q1 | $135K | Sell |
32,827
-1,897
| -5% | -$8.89K | ﹤0.01% | 2137 |
|
|
2019
Q4 | $167K | Buy |
34,724
+342
| +1% | +$1.89K | ﹤0.01% | 2322 |
|
|
2019
Q3 | $208K | Sell |
34,382
-239
| -0.7% | -$1.49K | ﹤0.01% | 2144 |
|
|
2019
Q2 | $225K | Buy |
34,621
+1,556
| +5% | +$11K | ﹤0.01% | 2151 |
|
|
2019
Q1 | $234K | Sell |
33,065
-1,072
| -3% | -$7.06K | ﹤0.01% | 2130 |
|
|
2018
Q4 | $166K | Sell |
34,137
-262
| -0.8% | -$1.36K | ﹤0.01% | 2289 |
|
|
2018
Q3 | $253K | Buy |
34,399
+621
| +2% | +$4.56K | ﹤0.01% | 2288 |
|
|
2018
Q2 | $216K | Buy |
33,778
+1,186
| +4% | +$7.84K | ﹤0.01% | 2306 |
|
|
2018
Q1 | $177K | Sell |
32,592
-1,752
| -5% | -$8.71K | ﹤0.01% | 2336 |
|
|
2017
Q4 | $143K | Buy |
34,344
+4,902
| +17% | +$29.5K | ﹤0.01% | 2531 |
|
|
2017
Q3 | $284K | Buy |
29,442
+2,201
| +8% | +$22.9K | ﹤0.01% | 2082 |
|
|
2017
Q2 | $322K | Buy |
27,241
+2,356
| +9% | +$30.1K | ﹤0.01% | 1992 |
|
|
2017
Q1 | $319K | Buy |
24,885
+1,802
| +8% | +$21.7K | ﹤0.01% | 1894 |
|
|
2016
Q4 | $283K | Sell |
23,083
-60
| -0.3% | -$713 | ﹤0.01% | 1971 |
|
|
2016
Q3 | $273K | Buy |
23,143
+35
| +0.2% | +$338 | ﹤0.01% | 1972 |
|
|
2016
Q2 | $201K | Sell |
23,108
-1,572
| -6% | -$10.8K | ﹤0.01% | 2131 |
|
|
2016
Q1 | $130K | Hold |
24,680
| – | – | ﹤0.01% | 3188 |
|
|
2015
Q4 | $192K | Sell |
24,680
-43
| -0.2% | -$330 | ﹤0.01% | 2889 |
|
|
2015
Q3 | $195K | Buy |
24,723
+29
| +0.1% | +$268 | ﹤0.01% | 2864 |
|
|
2015
Q2 | $224K | Sell |
24,694
-1,470
| -6% | -$14.8K | ﹤0.01% | 2899 |
|
|
2015
Q1 | $340K | Sell |
26,164
-1,200
| -4% | -$15.7K | ﹤0.01% | 2491 |
|
|
2014
Q4 | $372K | Sell |
27,364
-1,036
| -4% | -$11.6K | ﹤0.01% | 2390 |
|
|
2014
Q3 | $255K | Sell |
28,400
-19
| -0.1% | -$204 | ﹤0.01% | 2731 |
|
|
2014
Q2 | $385K | Buy |
28,419
+2,846
| +11% | +$29.7K | ﹤0.01% | 2393 |
|
|
2014
Q1 | $254K | Buy |
25,573
+585
| +2% | +$7.27K | ﹤0.01% | 2636 |
|
|
2013
Q4 | $333K | Buy |
24,988
+4,272
| +21% | +$51.9K | ﹤0.01% | 2337 |
|
|
2013
Q3 | $252K | Buy |
20,716
+19,516
| +1,626% | +$209K | ﹤0.01% | 2525 |
|
|
2013
Q2 | $12.4K | Buy |
+1,200
| New | +$16.5K | ﹤0.01% | 4074 |
|
American International Group's GNMK Position: Q2 2021 in Review
American International Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 40,588 shares — an estimated $970 sold.
American International Group first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $609K in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- American International Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- American International Group sold 40,588 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $970.
- American International Group first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- American International Group's GenMark Diagnostics, Inc position peaked at $609K in Q2 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.